43 tips from the desk this week. Latest: AAPL: a Good lower-entry put after a sharp rebound. Each tip shows the strike, the credit and the exit. The teasers are open; the full math unlocks with PRO.
A lower-entry Apple cash-secured put rated Good pairs reported cash generation with an active contract. Reversal risk, modest income and the event calendar keep the case conditional.
A lower-entry Microsoft cash-secured put rated Good pairs cloud growth with an active option contract. A sharp rally, moderate volatility rank and Ignite keep the case conditional.
A cash-secured bank put rated Good pairs a lower entry with reported interest-income growth. Conference risk, modest credit and a weak broader trend keep the case conditional.
A liquid lower-entry cash-secured put, rated Good, balances reported growth against a weak trend and negative free cash flow. Full contract, delayed snapshot and management plan inside.
Strong reported growth supports this lower-entry cash-secured put, rated Good. A damaged short-term trend, moderate IV rank and macro releases keep the risk real. Full contract and management plan inside.
Strong AWS growth and a lower entry support this Good cash-secured-put setup. Modest IV rank, AI spending and macro releases keep the risk real. Full trade specification and management plan inside.
Bristol Myers Squibb’s revenue outlook supports a lower-entry put, but mixed trend, reduced EPS guidance and imminent ASH news keep the rating at Good. Full setup and exit plan inside.
Abbott’s improving trend supports a lower-entry put, but nutrition litigation, moderate volatility and an unconfirmed earnings date keep the rating at Good. Full setup and exit plan inside.
GM’s rebound supports a lower-entry put. Earnings come after expiry, but dividend, listing-transfer and economic risks still matter. Full premium setup and exit plan inside.
Nike’s short-term rebound supports a lower-entry put setup, but Investor Day arrives before expiry. The full premium setup includes bid-based math, event risk and a defined exit review.
Apple’s post-results pullback creates a lower-entry put setup, but the damaged short-term trend and event calendar keep the rating at Good. Full trade and exit plan inside.
Pfizer’s raised outlook supports a lower-entry put, but the earnings call and dividend keep this a Good—not Great—setup. Full cash-risk and exit plan inside.